109
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Variation in Platelet Activation State in Pre-Donation Whole Blood: Effect of Time of Day and ABO Blood Group

ORCID Icon, , , &
Pages 283-292 | Published online: 03 Jun 2022

References

  • Becker RC, Sexton T, Smyth SS. Translational implications of platelets as vascular first responders. Circ Res. 2018;122(3):506–522. doi:10.1161/CIRCRESAHA.117.310939
  • Gupta S, Konradt C, Corken A, et al. Hemostasis vs. homeostasis: platelets are essential for preserving vascular barrier function in the absence of injury or inflammation. Proc Natl Acad Sci USA. 2020;117(39):24316–24325. doi:10.1073/pnas.2007642117
  • van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16(3):166–179. doi:10.1038/s41569-018-0110-0
  • Lesyk G, Jurasz P. Advances in platelet subpopulation research. Front Cardiovasc Med. 2019;6:138. doi:10.3389/fcvm.2019.00138
  • Thompson CB, Jakubowski JA. The pathophysiology and clinical relevance of platelet heterogeneity. Blood. 1988;72(1):1–8. doi:10.1182/blood.V72.1.1.1
  • Handtke S, Steil L, Greinacher A, Thiele T. Toward the relevance of platelet subpopulations for transfusion medicine. Front Med. 2018;5:17. doi:10.3389/fmed.2018.00017
  • Tomaiuolo M, Brass LF, Stalker TJ. Regulation of platelet activation and coagulation and its role in vascular injury and arterial thrombosis. Interv Cardiol Clin. 2017;6(1):1–12. doi:10.1016/j.iccl.2016.08.001
  • Spurgeon BEJ, Linden MD, Michelson AD, Frelinger AL 3rd:. Immunophenotypic analysis of platelets by flow cytometry. Curr Protoc. 2021;1(6):e178. doi:10.1002/cpz1.178
  • Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood. 1981;57(2):199–202. doi:10.1182/blood.V57.2.199.199
  • Beshkar P, Hosseini E, Ghasemzadeh M. Superior integrin activating capacity and higher adhesion to fibrinogen matrix in buffy coat-derived platelet concentrates (PCs) compared to PRP-PCs. Transfus Apher Sci. 2018;57(1):76–81. doi:10.1016/j.transci.2017.12.003
  • Musumeci V, Rosa S, Caruso A, Zuppi C, Zappacosta B, Tutinelli F. Abnormal diurnal changes in in-vivo platelet activation in patients with atherosclerotic diseases. Atherosclerosis. 1986;60(3):231–236. doi:10.1016/0021-9150(86)90170-X
  • Jafri SM, VanRollins M, Ozawa T, Mammen EF, Goldberg AD, Goldstein S. Circadian variation in platelet function in healthy volunteers. Am J Cardiol. 1992;69(9):951–954. doi:10.1016/0002-9149(92)90799-5
  • Undar L, Akkoç N, Alakavuklar MN, Cehreli C, Undar L. Flow cytometric analysis of circadian changes in platelet activation using anti-GMP-140 monoclonal antibody. Chronobiol Int. 1999;16(3):335–342. doi:10.3109/07420529909116862
  • Dalby MC, Davidson SJ, Burman JF, Davies SW. Diurnal variation in platelet aggregation with the PFA-100 platelet function analyser. Platelets. 2000;11(6):320–324. doi:10.1080/09537100050144731
  • Jovicić A, Mandić S. Circadian variations of platelet aggregability and fibrinolytic activity in healthy subjects. Thromb Res. 1991;62(1–2):65–74. doi:10.1016/0049-3848(91)90669-N
  • May JA, Fox S, Glenn J, Craxford S, Heptinstall S. Platelet function reduces significantly during the morning. Platelets. 2008;19(7):556–558. doi:10.1080/09537100802195405
  • Wiens L, Lutze G, Luley C, Westphal S. Platelet count and platelet activation: impact of a fat meal and day time. Platelets. 2007;18(2):171–173. doi:10.1080/09537100600930946
  • Atsma F, de Vegt F. The healthy donor effect: a matter of selection bias and confounding. Transfusion. 2011;51(9):1883–1885. doi:10.1111/j.1537-2995.2011.03270.x
  • Mousavi SA, Hermundstad B, Saether PC, Nybruket MJ, Knutsen TR, Llohn AH. Health behavior and lifestyle trends among platelet donors: results from a questionnaire-based survey in Norway. Biomed Res Int. 2021;2021:1–12. doi:10.1155/2021/8891885
  • Hilberg T, Menzel K, Gläser D, Zimmermann S, Gabriel HH. Exercise intensity: platelet function and platelet-leukocyte conjugate formation in untrained subjects. Thromb Res. 2008;122(1):77–84. doi:10.1016/j.thromres.2007.08.018
  • Mukamal KJ, Massaro JM, Ault KA, et al. Alcohol consumption and platelet activation and aggregation among women and men: the Framingham Offspring Study. Alcohol Clin Exp Res. 2005;29(10):1906–1912. doi:10.1097/01.alc.0000183011.86768.61
  • Nocella C, Biondi-Zoccai G, Sciarretta S, et al. Impact of tobacco versus electronic cigarette smoking on platelet function. Am J Cardiol. 2018;122(9):1477–1481. doi:10.1016/j.amjcard.2018.07.029
  • Peace AJ, Egan K, Kavanagh GF, et al. Reducing intra-individual variation in platelet aggregation: implications for platelet function testing. J Thromb Haemost. 2009;7(11):1941–1943. doi:10.1111/j.1538-7836.2009.03593.x
  • Becker RC, Tracy RP, Bovill EG, Mann KG, Ault K. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III thrombosis and anticoagulation group. Coron Artery Dis. 1994;5(4):339–345. doi:10.1097/00019501-199404000-00010
  • Holme S, Sweeney JD, Sawyer S, Elfath MD. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion. 1997;37(1):12–17. doi:10.1046/j.1537-2995.1997.37197176945.x
  • Wyant TL, Smith PC, Brown B, Kantor AB. Whole blood microvolume laser scanning cytometry for monitoring resting and activated platelets. Platelets. 2001;12(5):309–318. doi:10.1080/09537100120068206
  • Scheer FA, Michelson AD, Frelinger AL 3rd, et al. The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors. PLoS One. 2011;6(9):e24549. doi:10.1371/journal.pone.0024549
  • Jones CI, Garner SF, Angenent W, et al. Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus. J Thromb Haemost. 2007;5(8):1756–1765. doi:10.1111/j.1538-7836.2007.02632.x
  • Yee DL, Bergeron AL, Sun CW, Dong JF, Bray PF. Platelet hyperreactivity generalizes to multiple forms of stimulation. J Thromb Haemost. 2006;4(9):2043–2050. doi:10.1111/j.1538-7836.2006.02089.x
  • Schubert P, Devine DV. De novo protein synthesis in mature platelets: a consideration for transfusion medicine. Vox Sang. 2010;99(2):112–122. doi:10.1111/j.1423-0410.2010.01333.x
  • Curtis AM, Fitzgerald GA. Central and peripheral clocks in cardiovascular and metabolic function. Ann Med. 2006;38(8):552–559. doi:10.1080/07853890600995010
  • Westgate EJ, Cheng Y, Reilly DF, et al. Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation. 2008;117(16):2087–2095. doi:10.1161/CIRCULATIONAHA.107.739227
  • Haus E. Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention. Adv Drug Deliv Rev. 2007;59(9–10):966–984. doi:10.1016/j.addr.2006.11.002
  • West AS, Schønsted MI, Iversen HK. Impact of the circadian clock on fibrinolysis and coagulation in healthy individuals and cardiovascular patients – a systematic review. Thromb Res. 2021;207:75–84. doi:10.1016/j.thromres.2021.09.011
  • Rudnicka AR, Rumley A, Lowe GD, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation. 2007;115(8):996–1003. doi:10.1161/CIRCULATIONAHA.106.635169
  • Timm A, Fahrenkrug J, Jørgensen HL, Sennels HP, Goetze JP. Diurnal variation of von Willebrand factor in plasma: the Bispebjerg study of diurnal variations. Eur J Haematol. 2014;93(1):48–53. doi:10.1111/ejh.12298
  • Kapiotis S, Jilma B, Quehenberger P, Ruzicka K, Handler S, Speiser W. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. Circulation. 1997;96(1):19–21. doi:10.1161/01.CIR.96.1.19
  • Scheer FA, Hu K, Evoniuk H, et al. Impact of the human circadian system, exercise, and their interaction on cardiovascular function. Proc Natl Acad Sci USA. 2010;107(47):20541–20546. doi:10.1073/pnas.1006749107
  • Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987;69(6):1691–1695. doi:10.1182/blood.V69.6.1691.1691
  • Vallés J, Santos MT, Aznar J, et al. Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo. Blood. 2002;99(11):3978–3984. doi:10.1182/blood.V99.11.3978